Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07396038
What this trial is testing

INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerTURBTBladder Injury
Necmettin Erbakan University 1,000
Not applicableWithdrawnNCT02688348
What this trial is testing

Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00578526
What this trial is testing

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial

Who this might be right for
Urothelial CancerBladder CancerAdult
AHS Cancer Control Alberta 64
Not applicableUnknownNCT00126958
What this trial is testing

Cost-Effectiveness in Bladder Cancer

Who this might be right for
Bladder Cancer
Erasmus Medical Center 500
Not applicableActive Not RecruitingNCT06129084
What this trial is testing

Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

Who this might be right for
Metastatic Bladder CancerMetastatic Urothelial Carcinoma
Bernie Eigl 260
Early research (Phase 1)Looking for participantsNCT07140315
What this trial is testing

DK222 Study at Hopkins

Who this might be right for
Non-Small Cell Lung CancerUrothelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Not applicableLooking for participantsNCT07548476
What this trial is testing

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

Who this might be right for
Metastatic Bladder CancerPeripheral NeuropathyAdvanced Urothelial Cancer+3 more
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Testing effectiveness (Phase 2)Study completedNCT01687244
What this trial is testing

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
FKD Therapies Oy 40
Testing effectiveness (Phase 2)Study completedNCT01326871
What this trial is testing

ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of BladderUrethra CancerUreter Cancer+1 more
Altor BioScience 68
Not applicableStudy completedNCT02700464
What this trial is testing

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Who this might be right for
Bladder Cancer
Nucleix Ltd. 680
Early research (Phase 1)Study completedNCT04306900
What this trial is testing

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Who this might be right for
Solid Tumor, Adult
Trishula Therapeutics, Inc. 185
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT07097142
What this trial is testing

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
NRG Oncology 486
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT04779151
What this trial is testing

Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab

Who this might be right for
Urothelial Bladder CancerGastric AdenocarcinomaGastro-oesophageal Adenocarcinoma+5 more
Gustave Roussy, Cancer Campus, Grand Paris 51
Testing effectiveness (Phase 2)Ended earlyNCT01732107
What this trial is testing

Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression

Who this might be right for
Bladder Cancer
Noah Hahn, M.D. 13
Testing effectiveness (Phase 2)Ended earlyNCT04047693
What this trial is testing

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder CancerUrothelial CarcinomaNeoadjuvant Chemotherapy
Pusan National University Yangsan Hospital 24
Not applicableUnknownNCT04129606
What this trial is testing

Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy

Who this might be right for
Bladder CancerBladder Urothelial CarcinomaTrauma+5 more
Abdelwahab Hashem 300
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Next Page